Osteolabs GmbH is a biotechnology startup based in Germany, founded in 2018. The company's slogan "Experts for Bone Biomarkers" reflects its focus on early detection of individual osteoporosis risk and measuring therapy success using trace elements in the human body.
Originating from the GEOMAR Helmholtz Center for Ocean Research in Kiel, Osteolabs developed a groundbreaking early detection method for changes in bone calcium balance, based on a unique method for analyzing calcium isotopes, requiring only urine or blood for examination.
Notably, the startup secured a €1.60M Seed Round investment on 08 December 2020, from MBG Schleswig-Holstein mbH, Labor Dr. Krause & Kollegen MVZ, and SVM Verwaltungsgesellschaft, reaffirming its innovative approach and potential for disrupting the biotechnology, healthcare, and pharmaceutical industries.